Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.
As a privately-held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.
Founded in 2008, Coriolis is the expert in the development of liquid and lyophilized formulations, process development for freeze-drying, as well as analytical services including GMP (Good Manufacturing Practice) and release analysis.
We have supported the successful development of many drug products and our scientists are eager to apply their experience on a large range of molecules (including proteins, peptides, monoclonal antibodies, nucleic acids, advanced therapy medicinal products (ATMPs), vaccines, viruses, virus-like particles and GMOs) to your project.
Our facts & figures
Foundation of Coriolis Pharma
Move to the IZB (Innovation and Start-Up Center for Biotechnology) in Martinsried
Biological Safety Level (BSL) 1 & 2 certification
Move to new facilities in Martinsried
10th anniversary of Coriolis Pharma
Expansion into new facilities for ATMP development (up to BSL2)